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Introduction: Most aspects of implant-assisted reconstruction of pelvic ﬂoor in males and females are
under debate and the research is not standardized. Registries are supposed to shed light to the in-
dications, surgical techniques and material properties and to establish a standardized evaluation.
Methods: A working group was formed to create an online platform for registration and outcome
measurement of implant-assisted operations for pelvic organ prolapse (POP) and female and male stress
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TVT Tension-free Vaginal Tapefollow up in the registry to prove the feasibility of the registry. For validation a previously published
modiﬁed “satisfaction, anatomy, continence, safety e S.(A.)C.S score” was used.
Results: A consensus was met on deﬁnitions and classiﬁcations of patient variables, surgical procedures
and implants, as well as outcome parameters (efﬁcacy, continence, satisfaction, complications). Different
subgroup modules were formed in accordance with treated condition. The maximum score of cure was
reached by 25e100% of patients depending on the indication.
Conclusion: A prospective registry in accordance with IDEAL-D framework is justiﬁed for the evaluation
and regulation of implants for pelvic ﬂoor reconstruction.
© 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.d
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To reduce the risk of recurrence, mesh-assisted repair of the
pelvic ﬂoor has been introduced since the 1990's. First ofﬁcial
approval of meshes by the Food and Drug Administration (FDA)
dates back to 2003. To legalize the application of various prolapse
and incontinence meshes the FDA approved a premarket equiva-
lence notiﬁcation 510(k). No clinical testing was demanded for the
approval. In the last decade, the growing number of mesh opera-
tions and various presumed easy-to-use mesh kits from various
manufacturers led to a widespread application of this outpatient
surgical method [1,2]. Less attention was paid to possible new
complications and only a few clinical trials were available prior to
product approval and application [3,4].
Several FDAwarnings from 2008 to 2016, reported on signiﬁcant
number of serious complications after the application of vaginal
meshes or slings for POP and SUI repair. They proposed a higher
risk-class for the approval of these medical products [2,5]. FDA
reported mesh related complications including chronic pain, mesh
infection, dyspareunia and long-term complications (mesh erosion
and shrinkage), which were not analyzed in available studies. First,
there was almost no reaction of the industry and surgeons to these
warnings. Meanwhile, many manufacturers are confronted with a
total of more than 100.000 law suits [6]. The consequence was a
decrease of up to 40e60% implant-assisted operationsmostly in theUSA and this trend spills over into Europe and other continents [7].
Moreover, FDA released another announcement in 2016,
demanding clinical trials prior to application of vaginal meshes for
prolapse surgery. Otherwise, the products would be abandoned
frommarket approval in the USA [5]. The scientiﬁc societies reacted
and proposed a cautious application for alloplastic materials.
Standardized classiﬁcation of mesh related complications was
proposed by International Continence Society (ICS) and Interna-
tional Urogynecological Association (IUGA) [3]. European Com-
mission assigned the Scientiﬁc Committee on Emerging and Newly
Identiﬁed Health Risks (SCENIHR) to clarify the safety of surgical
meshes in urogynecology. The current release notiﬁes the insufﬁ-
cient scientiﬁc data and proposes a better education and the con-
duction of long-term trials, guidelines and registries (http://ec.
europa.eu/health/scientiﬁc_committees/consultations/public_
consultations/scenihr_consultation_27_en.htm) (last access
25.07.2016).
An outstanding example for the evaluation and regulation of
surgical products and techniques is the IDEAL system of surgical
innovation, which proposes an adequate Good Clinical Practice
(GCP) - similar process of evaluation and approval of surgical
techniques and medical devices. The method was initially
described 2009 by Peter McCulloch and includes 5 consecutive
steps of innovation: preclinical stage (Stage 0), idea (Stage 1),
development and exploration (Stage 2), assessment (Stage 3) and
long-term follow up (Stage 4) (Fig. 1) [1]. An IDEAL-D(evice)
framework on the evaluation of medical devices has been pub-
lished recently [8].
Herewith, we present the ﬁrst application of IDEAL-D frame-
work for the evaluation of urogynecological implants. A case series
with an early registry is introduced to prove the feasibility of
IDEAL-D system. The registry includes all implants for male and
female incontinence and female prolapse surgery.2. Materials and methods
2.1. Expert panel
Based on the successful implementation of surgical hernia reg-
istries, German quality assurance system and registry for hernia
surgery (Herniamed) and European registry for abdominal wall
hernias (EuraHs), a working group was formed to create an online
platform for registration and outcome measurement of operations
with application of implants for POP and SUI repair. Development
of the registry involved reaching agreement on clear deﬁnitions
and classiﬁcations of patient variables, surgical procedures and
implantmaterials used, as well as outcome parameters, the triple P-
triangle of pelvic ﬂoor reconstructions (Fig. 2) [9]. The working
group comprised of an interdisciplinary expert panel under aus-
pices of the German Society of Residents in Urology (GeSRU) and
the Study Group for Urogynecology and Plastic Pelvic Floor
Fig. 1. IDEAL-D framework of the evaluation and regulation of medical devices [8].
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Fig. 2. The triple P-triangle of pelvic ﬂoor repair, adopted from EuraHS [9].
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Obstetrics. Over several working group meetings, consensus was
reached on ICS and IUGA - based deﬁnitions and parameters for the
data to be recorded in the registry [10]. Existing classiﬁcations were
used where possible. However, many variables have been
described, deﬁned and classiﬁed by the working group.
2.2. Registry
The scope of the registry will include all surgeries for SUI and
POP repair with application of implants: vaginal and abdominal
meshes, female and male slings, artiﬁcial sphincter, reconstructive
surgery with alloplastic materials. Adult male and female patientsolder than 18 years should be included. The database will be used
on a voluntary basis. A stratiﬁcation of users will be offered. A Level
1 user will only have a small number of compulsory data ﬁelds to
complete the registration of a case. These data will involve the
variables needed for classiﬁcation of incontinence and pelvic pro-
lapse, the surgical technique and the materials used during the
repair. Uploading a case should only take a few minutes. A Level 2
user will have the availability to complete a more comprehensive
number of variables including detailed medical history, risk factors,
detailed information on surgical technique and complications.
The surgeon uploading a case using his or her account will be
the owner of the data. Various statistical analyses can be started
from the web interface. The users will be able to extract their data
in tables and in diagrams. Acknowledgement of the database as the
source of the data has to be made every time it is used in public or
in publications. However, the registry will not contain personal data
like names or date of birth and will thus be completely anonymous.
The link between the registration number and the patients' identity
and the regular follow up 6 weeks, 6 months and annually after the
initial surgery will be the responsibility of the user. To simplify the
follow up, patients and referring physicians will be interviewed by
telephone or mail. Additionally patients will be provided with
implant identity cards. Pop-up windows with explanations of def-
initions, ﬁgures etc. are available on the platform. A registry logo is
agreed upon and a website (http://winc030.informatik.uni-
wuerzburg.de:8080/) with access to the database is provided
(Fig. 3). The online platform for the registry was developed at the
department of Artiﬁcial Intelligence and Applied Informatics, part
of the Institute for Mathematics and Computer Science, at the
University of Würzburg in Germany, under the supervision of Prof.
Dr. Frank Puppe. The data were stored at the secured server area. A
test-phase on the performance of the platform has been conducted
by the working group members from October 2015 till March 2016.
The work has been reported in line with the PROCESS criteria [11].
Additionally the study was registered at Research Registry, regis-
tration number researchregistry1149.2.3. Ethics
All procedures performed in this study were in accordance with
Fig. 3. Logo of registry of urogynecological implants.
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committee and with the 1964 Helsinki Declaration and its later
amendments or comparable ethical standards. An ethics committee
vote is not necessary for this feasibility study, as a retrospective
design was chosen to present the details of registry formation.
2.4. Patients
After obtaining corresponding informed consent, the ﬁrst 20
patients (16 females and 4 males) with the application of a modi-
ﬁed mesh-assisted SUI and POP repair have been evaluated as a
consecutive case series and included in the registry. A retrospective
study design was applied to evaluate the feasibility of the registry.
Different mesh materials were used (TVT®, Seratim®, Ultrapro®,
Vitamesh®) and were all modiﬁed by a new technique with pre-
operative surface coating with autologous plasma [12]. The tech-
nique has been evaluated previously in accordance with preclinical
IDEAL stage 0 [13]. For the purpose of implant coating, 20e40 ml
blood sample were obtained in the EDTA-tube (Ethyl-
enediaminetetraacetic acid) from the respective patient by vein
puncture before the induction of anesthesia and the clear super-
natant (plasma) after centrifugation of the precipitation was
removed with sterile syringe. Before the implantation the meshes
were incubated for 30minwith 10e20ml (depending on the size of
the mesh) autologous plasma. The surgical technique was not
altered by the application of this technology. The patients were
examined pre- and postoperatively and interviewed before the
operation and on telephone or per email after the operation.
2.5. Outcome evaluation
In reporting the goals of the surgery a previously published,
practicable and timely S.A.C.S. score was adopted and used 24
months after the initial prolapse surgery, for the evaluation of male
and female incontinence a modiﬁed S.C.S. (sat-
isfactionecontinenceesafety) - score was used [14]:
e Satisfaction: to test patient's perception of success and the
subjective measure of satisfaction, we used the validated version of
Patient Global Improvement Inventory (PGI-I) scale. The surgery
was deﬁned as successful, if the patient felt “much better” or “very
much better” after the surgery. Value ¼ 1.
e Anatomy: to verify anatomical success of POP surgery, we used
the POPeQ, which refers to an objective, site-speciﬁc system for
describing, quantifying, and staging pelvic support in women. Ac-
cording to the POP-Q, we used very stringent criteria for the deﬁ-
nition of complete success (the absence of any 2 stage prolapse).
This parameter was only used for female POP evaluation. Value¼ 1.e Continence: for the deﬁnition and grading of postoperative
continence, we administered the validated ICIQ-SF2004 question-
naire, post-operative pad use and the Ingelman-Sundberg scale
(score 0e3); for the score, we considered a complete success the
absence of any degree of urine leakage and the use of no pad or only
a protective pad. Value ¼ 1.
e Safety: to analyze the safety of the procedure, we used the ICS/
IUGA and ClavieneDindo-classiﬁcation of surgical complications
(score 0e5) [7,15]. The absence of perioperative or delayed revision
surgery due to a complication except for intraoperative bladder
perforation (commonly not assumed as a severe complication) was
deﬁned as success. Value ¼ 1.
Each component of the scoring system produced a binary
nominal categorical variable (1 or 0). Perfect scoring systems, ac-
cording to the S.(A.)C.S., were deﬁned as the sum of satisfaction
(plus anatomy) plus continence plus safety, with a total score of 4
for POP and a total score of 3 for SUI representing a ‘cure’. The
degree of concordance among these scores was estimated using
Cohen's kappa test of inter-rater agreement (with k-values ranging
from 0 to 1).3. Results
All pelvic ﬂoor reconstruction surgeries with application of
implants like abdominal and transvaginal mesh or biological ma-
terials, male and female sling, and artiﬁcial sphincter were included
and different modules were created. A set of well-described deﬁ-
nitions, risk factors for recurrences and complications was listed. A
comprehensive information on management strategies for com-
plications can be provided by the user in Level 2. An online platform
with statistical analysis was established, which can be used by in-
dividual surgeons, teams or for multicentre studies. The question-
naires were evaluated for the perioperative data of the ﬁrst 20
patients. The ﬁrst results showed the feasibility and the timely
application of the registry. The data was entered by 3 different
users, all Level 2 with minimum 2 follow ups after the initial im-
plantation. All follow ups were done by telephone interview, a form
of patient related outcome (PROM). The data on postoperative
anatomy outcome was retrieved from referring physicians. The
mean time for the data input (Level 2, extended) in the database
was 18 min (range 12e26).
Between 04/2013 and 05/2014, 20 patients (16 females and 4
males) with the indication for SUI and POP repair with mesh graft
were selected for surgery in a single institution. The mean age was
67 years (45e85) and the mean follow up was 23 months (17e29).
11 patients were treated for SUI (grades II-III, Stamey score) and 9
patients were treated for POP (POP-Q grades IIeIII, anterior and
apical prolapse).
Three reoperations (15%) were needed due to complications (2
postoperative obstructions after TVT-procedure, 1 abdominal her-
nia 12 months postoperative after abdominal sacrocolpopexy). No
other severe complications (mesh exposure, bladder or bowel
injury, and ﬁstula) were registered. Two reoperations (10%) were
needed for persisting incontinence or prolapse (Table 1).
According to the S.(A.)C.S. scoring system, only 13 patients (65%,
Table 1) reached the cumulative perfect score of 3 for SUI or 4 for
POP at 24-month follow-up: high PGI-I score, no residual prolapse
2 according to the POP-Q staging system, no pad use (or no more
than one protective pad), and no grade >2 complication nor
delayed surgery related complications. However, signiﬁcant dif-
ferences between the procedures could be found with maximum
100% for anterior vaginal mesh vs. 25% for TOT male incontinence
surgery. The highest agreement with S.(A.)C.S. score was reached
for the satisfaction component of the score (Cohen's k ¼ 0.88).
Table 1
Classiﬁcation of complications and S.(A.)C.S. score [14].
Procedure TVT TOT Ant. Vag. mesh Sacropexy Total IUGA/ICS-class.
Number of patients (gender) 7 (female) 4 (male) 1 (female) 8 (female) 20
Complications, number (%)
Clavien-Dindo Grade I
Prolonged pain 0 1 (25%) 0 1 (12.5%) 2 (10%) 6Bd T2 S3/S4
Hematoma 1 (14%) 1 (25%) 0 0 2 (10%) 7A T2 S2-S4
Urge de Novo 3 (43%) 1 (25%) 0 0 3 (15%) 4B T2
Obstructive micturition (prolonged catheter) 1 (14%) 0 1 (100%) 0 2 (10%) 4B T2
UTI 2 (28%) 0 0 2 (25%) 4 (25%) 4B T2
Clavien-Dindo Grade II Wound infection 0 0 0 1 (12.5%) 1 (5%) 6Cb T2 S4
Clavien-Dindo Grade Grade III
Obstructive micturition 2 (28%) 0 0 0 2 (10%) 4B T2
Hernia 0 0 0 1 (12.5%) 1 (5%) 6Bd T3 S5
Reopeartion for SUI/POP 0 1 (25%) 0 1 (12.5%) 1
Clavien-Dindo Grade Grade IV-V 0 0 0 0 0
S.(A.)C.S score
Satisfaction 6 (86%) 1 (25%) 1 (100%) 6 (75%)
Anatomy na na 1 (100%) 6 (75%)
Continence 7 (100%) 1 (25%) 1 (100%) 8 (100%)
Safety 5 (71%) 4 (100%) 1 (100%) 7 (87%)
S.(A.)C.S score 4 5 (71%) 1 (25%) 1 (100%) 6 (75%) 13 (65%)
S.(A.)C.S score 1e2 2 (14%) 3 (75%) 0 2 (25%) 7 (35%)
na, not applicable
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A restart for the application and indication of alloplastic mate-
rials for pelvic ﬂoor reconstruction and standardized quality trials
are needed urgently. We need to know the quality of our surgeries
and educate the patients properly about possible complications.
Mesh-related complications like erosion, exposure, infection, pelvic
pain and mesh shrinkage should be considered and risk factors
should be identiﬁed [3]. However, there is a number of late mesh-
related complications, so that a long-term follow up is important
for a proper evaluation of the procedure [16].
There are several reasons for the preliminary fail of the implants
in urogynecology. Different modiﬁcations of a surgical technique,
indications and follow up are not standardized. The main problem
is the approval of medical products. The pharmacological studies
are regulated by strict rules requiring phase I-III studies according
to GCP. The medical products are less strictly regulated and can get
approval without quality studies [1,6]. However, the difﬁculty is to
evaluate medical devices with a clinical study. It is possible to look
for a correlation between the medicament and a symptom in a
pharmaceutical trial. In contrast, the result of a surgical procedure
depends on many different factors. Thus, numerous subgroup and
multivariate analyses with large patient cohorts would be neces-
sary. Randomized clinical trials (RCT) remain the source of the best
evidence for pharmaceuticals. In contrast, they are not always
practicable for medical products. In a RCT, the randomized
controlled variable is just one out of many. The long delay from
surgery to the development of many complications such as recur-
rence and the impossibility to control all relevant parameters can
hinder proof of the signiﬁcant impact, in particular, when studying
slight modiﬁcations of techniques or materials.
A functional solutionwith a simple approval of medical products
without restrictions concerning the products efﬁcacy and the safety
of patients is obviously required. IDEAL-D is a simple and practi-
cable system for the evaluation of medical devices. Surveillance by
registries from small series would be an important part of IDEAL
and would allow opportunities for using risk adjustment tech-
niques to analyze large registry datasets to study small or long term
effects in situations with multiple confounders, in which a ran-
domized trial might be infeasible [8]. However, projects like IDEAL
are still at their beginning and consensus on key outcomes (e.g.functional results, scope and severity of complications) as well as
contextual factors (e.g. grading of patient risk factors, severity of
comorbid pathology or general health, details of surgical technique
and perioperative setting) will need consensus among specialist
communities and specialities as well as journals in order to stan-
dardize reporting accordingly.
A registry allows the detection of poor and good results, if they
appear more frequently than expected. Surgical hernia registries in
general and national registries, like the Swedish TVT database and
the Austrian TVT database have been previously successfully
established and improved the quality of surgery after the imple-
mentation [17,18]. However, the Austrian registry was timely
limited and Swedish registry is obligatory and under auspices of the
government. The Austrian and Swedish models are not transferable
to other bigger countries. Hereby, we conﬁrm the feasibility of the
presented registry with the possibility of timely and effective data
entry. Further, we adopted a previously published simple score
system to evaluate the surgical technique for POP and SUI repair.
The 4-point S (satisfaction), A (anatomy), C (continence), S (safety) -
score was presented by Mearini et al. to evaluate 233 women 24
months after open sacrocolpopexy [13]. The authors detected the
sensitivity of 74.1%, the speciﬁcity of 90% and a total diagnostic
capacity of 75.5% for the new score. According to the S.A.C.S. scoring
system, only 160 patients (68.6%) reached the maximum score of
cure in the above mentioned study. We applied the score for female
POP implant surgery and modiﬁed it for female and male SUI
implant surgery and used here a simpliﬁed S.C.S. score for evalua-
tion, as the anatomy cannot be considered. In our collective, 13
patients (65%, Table 1) reached the cumulative perfect score of 3 or
4 at 24-month follow up, these results are similar to the data of
Mearini et al. and were stable after 24 months. We found as well a
strong agreement of the score and satisfaction. However, an inter-
nal validation was not applicable due to a heterogenic and small
patient collective.
The main limitation of this study is the inclusion of male and
female with different POP and SUI methods, which should be
evaluated on each own. Further statistical analyses like logistic
regression to analyze the possible risk factors for the outcomewere
not applicable due to small patient numbers. Another problem is
the future interpretation of the results. Less than 70% of the whole
group reached a perfect S.(A.)C.S. score, in the male SUI group only
Fig. 4. Registry expansion process.
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the future to decide which procedure or implant does not meet the
quality standards. Another limitation is the large time amount
required for the data input. A timely solution with effective ques-
tionnaire are needed for high and consistent study number. How-
ever, ﬁrst results show the feasibility and the value of the database.
The aim of our study was to present a preliminary model on how to
establish a long-term database for the evaluation of new implant
techniques for POP and SUI repair in female and male. However,
further proofs and internal and external validations on large col-
lectives are necessary. A prospective registry-based evaluation of
different indications and procedures, as described in this study, will
shed light into the role of implants for the reconstruction of pelvic
ﬂoor. The evaluation of the registry should be done by an inde-
pendent committee under auspices of national and international
scientiﬁc societies. The funding, obliged to register application of
implants and regulation of the approval process should be provided
by Medical Device Regulation authorities.
Given the fact, that IDEAL is an international collaboration, a fast
international spread and improvement of the registry by publica-
tions and congress presentations can be expected. Recently a ﬁrst
outcome of the registry with a randomized trial protocol, exploring
a new mesh improvement for pelvic organ prolapse surgery, has
been published [19]. The participating scientiﬁc societies and in-
dustrial manufacturers will expand and update the registry to-
wards a multi-country or multi-continent presence (Fig. 4). Our
group is a member of “the national dialogue on implant register”,
which is a part of a national strategy process “Innovations in
medical technology” supported by the Federal Institute for Drugs
and Medical Devices, the Federal Ministry of Economics and
Technology, the Federal Ministry of Education and Research and the
Federal Ministry of Health. The meshes will be classiﬁed as a class
III high-risk product by the upcoming EUmedical device regulation
and the postmarket follow up data will be required prior to
approval. An implementation of quality depending reimbursement
is planned by the politics. A successful registry based on the
experience and consent of participating gynecological and uro-
logical societies will pave the way for the mandatory registry sys-
tem driven by politics and with the ﬁnancial support of theparticipating industrial manufacturers.
Registries according to the IDEAL method of surgical innovation
allow a standardized follow up of different techniques and implants
and a better preoperative counseling of patients by surgeons, based
on each individual's clinical situation.
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